Table 1.
CD (n = 167) |
UC (n = 105) |
IBD-U (n = 7) |
|
---|---|---|---|
Colonoscopy | 167 (100%) | 105 (100%) | 7 (100%) |
Terminal ileocolonoscopy | 153 (90.3%) | 91 (86.4%) | 6 (85.8%) |
Upper GI endoscopy | 158 (93.2%) | 81 (76.9%) | 7 (100%) |
Abdominal ultrasound | 167 (100%) | 105 (100%) | 7 (100%) |
Small bowel follow-through | 42 (24.7%) | 5 (4.7%) | 0 (0%) |
Scintigraphy with labeled leucocytes | 21 (12.4%) | 8 (7.6%) | 0 (0%) |
Capsule endoscopy∗ | 87 (51.3%) | 11 (10.4%) | 4 (57.2%) |
Magnetic resonance imaging (MRI)+ | 18 (10.6%) | 2 (1.9%) | 2 (28.6%) |
Computed tomography (CT) | 5 (2.9%) | 0 (0%) | 0 (0%) |
∗Capsule endoscopy has been available since 2006.
+MR enterography has been available since 2009.